Skip to main content
Erschienen in: Pediatric Radiology 11/2019

01.10.2019 | Pediatric oncologic imaging

Whole-body magnetic resonance imaging of pediatric cancer predisposition syndromes: special considerations, challenges and perspective

verfasst von: Sandra Saade-Lemus, Andrew J. Degnan, Michael R. Acord, Abhay S. Srinivasan, Janet R. Reid, Sabah E. Servaes, Lisa J. States, Sudha A. Anupindi

Erschienen in: Pediatric Radiology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Cancer predisposition syndromes increase the incidence of tumors during childhood and are associated with significant morbidity and mortality. Imaging is paramount for ensuring early detection of neoplasms, impacting therapeutic interventions and potentially improving outcome. While conventional imaging techniques involve considerable exposure to ionizing radiation, whole-body MRI is a radiation-free modality that allows continuous imaging of the entire body and has increasingly gained relevance in the surveillance, diagnosis, staging and monitoring of pediatric patients with cancer predisposition syndromes. Nevertheless, widespread implementation of whole-body MRI faces several challenges as a screening tool. Some of these challenges include developing clinical indications, variability in protocol specifications, image interpretation as well as coding and billing practices. These factors impact disease management, patient and family experience and research collaborations. In this discussion we review the aforementioned special considerations and the potential direction that might help overcome these challenges and promote more widespread use of whole-body MRI in children with cancer predisposition syndromes.
Literatur
1.
Zurück zum Zitat Monsalve J, Kapur J, Malkin D, Babyn PS (2011) Imaging of cancer predisposition syndromes in children. Radiographics 31:263–280CrossRef Monsalve J, Kapur J, Malkin D, Babyn PS (2011) Imaging of cancer predisposition syndromes in children. Radiographics 31:263–280CrossRef
2.
Zurück zum Zitat Parsons DW, Roy A, Yang Y et al (2016) Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors. JAMA Oncol 2:616–624CrossRef Parsons DW, Roy A, Yang Y et al (2016) Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors. JAMA Oncol 2:616–624CrossRef
3.
Zurück zum Zitat Ripperger T, Bielack SS, Borkhardt A et al (2017) Childhood cancer predisposition syndromes — a concise review and recommendations by the Cancer predisposition working group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A 173:1017–1037 Ripperger T, Bielack SS, Borkhardt A et al (2017) Childhood cancer predisposition syndromes — a concise review and recommendations by the Cancer predisposition working group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A 173:1017–1037
4.
Zurück zum Zitat Villani A, Shore A, Wasserman JD et al (2016) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol 17:1295–1305CrossRef Villani A, Shore A, Wasserman JD et al (2016) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol 17:1295–1305CrossRef
5.
Zurück zum Zitat Kratz CP, Achatz MI, Brugieres L et al (2017) Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res 23:e38–e45CrossRef Kratz CP, Achatz MI, Brugieres L et al (2017) Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res 23:e38–e45CrossRef
6.
Zurück zum Zitat Kamihara J, Bourdeaut F, Foulkes WD et al (2017) Retinoblastoma and neuroblastoma predisposition and surveillance. Clin Cancer Res 23:e98–e106CrossRef Kamihara J, Bourdeaut F, Foulkes WD et al (2017) Retinoblastoma and neuroblastoma predisposition and surveillance. Clin Cancer Res 23:e98–e106CrossRef
7.
Zurück zum Zitat Friedman DN, Lis E, Sklar CA et al (2014) Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study. Pediatr Blood Cancer 61:1440–1444CrossRef Friedman DN, Lis E, Sklar CA et al (2014) Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study. Pediatr Blood Cancer 61:1440–1444CrossRef
8.
Zurück zum Zitat Evans DGR, Salvador H, Chang VY et al (2017) Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1. Clin Cancer Res 23:e46–e53CrossRef Evans DGR, Salvador H, Chang VY et al (2017) Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1. Clin Cancer Res 23:e46–e53CrossRef
9.
Zurück zum Zitat Evans DGR, Salvador H, Chang VY et al (2017) Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders. Clin Cancer Res 23:e54–e61CrossRef Evans DGR, Salvador H, Chang VY et al (2017) Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders. Clin Cancer Res 23:e54–e61CrossRef
10.
Zurück zum Zitat Rednam SP, Erez A, Druker H et al (2017) Von Hippel-Lindau and hereditary pheochromocytoma/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res 23:e68–e75CrossRef Rednam SP, Erez A, Druker H et al (2017) Von Hippel-Lindau and hereditary pheochromocytoma/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res 23:e68–e75CrossRef
11.
Zurück zum Zitat Jasperson KW, Kohlmann W, Gammon A et al (2014) Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families. Familial Cancer 13:257–265CrossRef Jasperson KW, Kohlmann W, Gammon A et al (2014) Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families. Familial Cancer 13:257–265CrossRef
12.
Zurück zum Zitat Tabori U, Hansford JR, Achatz MI et al (2017) Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood. Clin Cancer Res 23:e32–e37CrossRef Tabori U, Hansford JR, Achatz MI et al (2017) Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood. Clin Cancer Res 23:e32–e37CrossRef
13.
Zurück zum Zitat Hricak H, Brenner DJ, Adelstein SJ et al (2011) Managing radiation use in medical imaging: a multifaceted challenge. Radiology 258:889–905CrossRef Hricak H, Brenner DJ, Adelstein SJ et al (2011) Managing radiation use in medical imaging: a multifaceted challenge. Radiology 258:889–905CrossRef
14.
Zurück zum Zitat Brady Z, Ramanauskas F, Cain TM, Johnston PN (2012) Assessment of paediatric CT dose indicators for the purpose of optimisation. Br J Radiol 85:1488–1498CrossRef Brady Z, Ramanauskas F, Cain TM, Johnston PN (2012) Assessment of paediatric CT dose indicators for the purpose of optimisation. Br J Radiol 85:1488–1498CrossRef
15.
Zurück zum Zitat Smith EA, Dillman JR (2016) Current role of body MRI in pediatric oncology. Pediatr Radiol 46:873–880CrossRef Smith EA, Dillman JR (2016) Current role of body MRI in pediatric oncology. Pediatr Radiol 46:873–880CrossRef
16.
Zurück zum Zitat Nievelstein RA, Littooij AS (2016) Whole-body MRI in paediatric oncology. Radiol Med 121:442–453CrossRef Nievelstein RA, Littooij AS (2016) Whole-body MRI in paediatric oncology. Radiol Med 121:442–453CrossRef
17.
Zurück zum Zitat Atkin KL, Ditchfield MR (2014) The role of whole-body MRI in pediatric oncology. J Pediatr Hematol Oncol 36:342–352CrossRef Atkin KL, Ditchfield MR (2014) The role of whole-body MRI in pediatric oncology. J Pediatr Hematol Oncol 36:342–352CrossRef
18.
Zurück zum Zitat Chavhan GB, Babyn PS (2011) Whole-body MR imaging in children: principles, technique, current applications, and future directions. Radiographics 31:1757–1772CrossRef Chavhan GB, Babyn PS (2011) Whole-body MR imaging in children: principles, technique, current applications, and future directions. Radiographics 31:1757–1772CrossRef
19.
Zurück zum Zitat Anupindi SA, Bedoya MA, Lindell RB et al (2015) Diagnostic performance of whole-body MRI as a tool for cancer screening in children with genetic cancer-predisposing conditions. AJR Am J Roentgenol 205:400–408CrossRef Anupindi SA, Bedoya MA, Lindell RB et al (2015) Diagnostic performance of whole-body MRI as a tool for cancer screening in children with genetic cancer-predisposing conditions. AJR Am J Roentgenol 205:400–408CrossRef
20.
Zurück zum Zitat Greer MC (2018) Imaging of cancer predisposition syndromes. Pediatr Radiol 48:1364–1375CrossRef Greer MC (2018) Imaging of cancer predisposition syndromes. Pediatr Radiol 48:1364–1375CrossRef
21.
Zurück zum Zitat Gottumukkala RV, Gee MS, Hampilos PJ, Greer MC (2019) Current and emerging roles of whole-body MRI in evaluation of pediatric cancer patients. Radiographics 39:516–534CrossRef Gottumukkala RV, Gee MS, Hampilos PJ, Greer MC (2019) Current and emerging roles of whole-body MRI in evaluation of pediatric cancer patients. Radiographics 39:516–534CrossRef
22.
Zurück zum Zitat Greer MC, Voss SD, States LJ (2017) Pediatric cancer predisposition imaging: focus on whole-body MRI. Clin Cancer Res 23:e6–e13CrossRef Greer MC, Voss SD, States LJ (2017) Pediatric cancer predisposition imaging: focus on whole-body MRI. Clin Cancer Res 23:e6–e13CrossRef
23.
Zurück zum Zitat Anupindi SA (2019) Imaging of children with cancer predisposition. In: Voss S (ed) Imaging in pediatric oncology. Springer International Publishing, Basel Anupindi SA (2019) Imaging of children with cancer predisposition. In: Voss S (ed) Imaging in pediatric oncology. Springer International Publishing, Basel
24.
Zurück zum Zitat Villani A, Tabori U, Schiffman J et al (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol 12:559–567CrossRef Villani A, Tabori U, Schiffman J et al (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol 12:559–567CrossRef
25.
Zurück zum Zitat Ballinger ML, Best A, Mai PL et al (2017) Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis. JAMA Oncol 3:1634–1639CrossRef Ballinger ML, Best A, Mai PL et al (2017) Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis. JAMA Oncol 3:1634–1639CrossRef
26.
Zurück zum Zitat Ballinger ML, Ferris NJ, Moodie K et al (2017) Surveillance in germline TP53 mutation carriers utilizing whole-body magnetic resonance imaging. JAMA Oncol 3:1735–1736CrossRef Ballinger ML, Ferris NJ, Moodie K et al (2017) Surveillance in germline TP53 mutation carriers utilizing whole-body magnetic resonance imaging. JAMA Oncol 3:1735–1736CrossRef
27.
Zurück zum Zitat Vutskits L, Davidson A (2017) Update on developmental anesthesia neurotoxicity. Curr Opin Anaesthesiol 30:337–342CrossRef Vutskits L, Davidson A (2017) Update on developmental anesthesia neurotoxicity. Curr Opin Anaesthesiol 30:337–342CrossRef
28.
Zurück zum Zitat Malkin D, Nichols KE, Schiffman JD et al (2017) The future of surveillance in the context of cancer predisposition: through the murky looking glass. Clin Cancer Res 23:e133–e137CrossRef Malkin D, Nichols KE, Schiffman JD et al (2017) The future of surveillance in the context of cancer predisposition: through the murky looking glass. Clin Cancer Res 23:e133–e137CrossRef
29.
Zurück zum Zitat Schooler GR, Davis JT, Daldrup-Link HE, Frush DP (2018) Current utilization and procedural practices in pediatric whole-body MRI. Pediatr Radiol 48:1101–1107CrossRef Schooler GR, Davis JT, Daldrup-Link HE, Frush DP (2018) Current utilization and procedural practices in pediatric whole-body MRI. Pediatr Radiol 48:1101–1107CrossRef
30.
Zurück zum Zitat Kornaczewski ER, Pointon OP, Burgess JR (2016) Utility of FDG-PET imaging in screening for succinate dehydrogenase B and D mutation-related lesions. Clin Endocrinol 85:172–179CrossRef Kornaczewski ER, Pointon OP, Burgess JR (2016) Utility of FDG-PET imaging in screening for succinate dehydrogenase B and D mutation-related lesions. Clin Endocrinol 85:172–179CrossRef
31.
Zurück zum Zitat Lauenstein TC, Freudenberg LS, Goehde SC et al (2002) Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 12:2091–2099CrossRef Lauenstein TC, Freudenberg LS, Goehde SC et al (2002) Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 12:2091–2099CrossRef
32.
Zurück zum Zitat Mohan S, Moineddin R, Chavhan GB (2015) Pediatric whole-body magnetic resonance imaging: intra-individual comparison of technical quality, artifacts, and fixed structure visibility at 1.5 and 3 T. Indian J Radiol Imaging 25:353–358CrossRef Mohan S, Moineddin R, Chavhan GB (2015) Pediatric whole-body magnetic resonance imaging: intra-individual comparison of technical quality, artifacts, and fixed structure visibility at 1.5 and 3 T. Indian J Radiol Imaging 25:353–358CrossRef
33.
Zurück zum Zitat Schmidt G, Dinter D, Reiser MF, Schoenberg SO (2010) The uses and limitations of whole-body magnetic resonance imaging. Dtsch Arztebl Int 107:383–389PubMedPubMedCentral Schmidt G, Dinter D, Reiser MF, Schoenberg SO (2010) The uses and limitations of whole-body magnetic resonance imaging. Dtsch Arztebl Int 107:383–389PubMedPubMedCentral
34.
Zurück zum Zitat Kellenberger CJ, Epelman M, Miller SF, Babyn PS (2004) Fast STIR whole-body MR imaging in children. Radiographics 24:1317–1330CrossRef Kellenberger CJ, Epelman M, Miller SF, Babyn PS (2004) Fast STIR whole-body MR imaging in children. Radiographics 24:1317–1330CrossRef
35.
Zurück zum Zitat Krohmer S, Sorge I, Krausse A et al (2010) Whole-body MRI for primary evaluation of malignant disease in children. Eur J Radiol 74:256–261CrossRef Krohmer S, Sorge I, Krausse A et al (2010) Whole-body MRI for primary evaluation of malignant disease in children. Eur J Radiol 74:256–261CrossRef
36.
Zurück zum Zitat Chung CY, Alson MD, Duszak R Jr, Degnan AJ (2018) From imaging to reimbursement: what the pediatric radiologist needs to know about health care payers, documentation, coding and billing. Pediatr Radiol 48:904–914CrossRef Chung CY, Alson MD, Duszak R Jr, Degnan AJ (2018) From imaging to reimbursement: what the pediatric radiologist needs to know about health care payers, documentation, coding and billing. Pediatr Radiol 48:904–914CrossRef
37.
Zurück zum Zitat Degnan AJ, Alson MD, Duszak R Jr (2019) Variability in billing practices for whole-body magnetic resonance imaging. Pediatr Radiol 49:153CrossRef Degnan AJ, Alson MD, Duszak R Jr (2019) Variability in billing practices for whole-body magnetic resonance imaging. Pediatr Radiol 49:153CrossRef
Metadaten
Titel
Whole-body magnetic resonance imaging of pediatric cancer predisposition syndromes: special considerations, challenges and perspective
verfasst von
Sandra Saade-Lemus
Andrew J. Degnan
Michael R. Acord
Abhay S. Srinivasan
Janet R. Reid
Sabah E. Servaes
Lisa J. States
Sudha A. Anupindi
Publikationsdatum
01.10.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 11/2019
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-019-04431-3

Weitere Artikel der Ausgabe 11/2019

Pediatric Radiology 11/2019 Zur Ausgabe

Pediatric oncologic imaging

Ovarian neoplasms of childhood

Pediatric oncologic imaging

Imaging of Wilms tumor: an update

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.